EGFR and lung cancer: (27) developed a model for predicting noninvasive small cell lung cancer (SCLC) versus NSCLC, alongside distinguishing epidermal growth factor receptor (EGFR) mutation type and wild-type NSCLC, based on PET/MRI images, amide proton transfer weighted imaging (APTWI), and diffusion-weighted imaging (DWI) in 99 lung cancer patients.